Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 41Breast 10Thoracic 6Gynecologic 6Other hematologic neoplasm 4Lymphoid 4Genitourinary 4Sarcoma 2Head & Neck 2Classical hematology 2CNS 2Other 1Endocrine 1Dermatologic 1

Conditions

Neuroendocrine Tumors 131Pituitary Neoplasms 72Thyroid Cancer, Papillary 59Pheochromocytoma 55Multiple Endocrine Neoplasia Type 1 31Thyroid Neoplasms 30Paraganglioma 29Adrenal Gland Neoplasms 27Neoplasms 26Pancreatic Neoplasms 21Carcinoid Tumor 20Adrenocortical Carcinoma 19Hyperaldosteronism 17Cushing Syndrome 17Carcinoma, Neuroendocrine 17Gastro-enteropancreatic neuroendocrine tumor 16Acromegaly 15Pituitary Diseases 14Lung Neoplasms 13Stomach Neoplasms 11Prostatic Neoplasms 11Neoplasm Metastasis 11Carcinoma, Hepatocellular 11Breast Neoplasms 11Multiple Endocrine Neoplasia 10Melanoma 10Thyroid Carcinoma, Anaplastic 9Prolactinoma 9Lymphatic Metastasis 9Insulinoma 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Postoperative Complications × Endocrine × Clear all
NCT06221020 2024-01-24

To Assess the Impact of theERAS Consensus on Patients With Endoscopic Pituitary Tumor Surgery

Chang Gung Memorial Hospital

Unknown
70 enrolled
Endocrine

Pituitary Neoplasms, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡